Central Nervous System (CNS) Drugs Market Research Report, Growth & Forecast

Gilenya is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventi...

Olanzapine is an atypical antipsychotic drugs, it is suitable for schizophrenia and other severe positive symptoms (for example: delusions, hallucinations, thought disorder, hostility and suspicion) a...

Perphenazine is a typical antipsychotic drug. Chemically, it is classified as a piperazinyl phenothiazine. Originally marketed in the US as Trilafon, it has been in clinical use for decades. Perphenaz...

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dem...

Amyotrophic lateral sclerosis (ALS) is also known as Lou Gehrig’s disease or Maladie De Charcot, it is a neurological disease that causes nerve cells to gradually break down and die.The cause is not k...

Alzheimer’s disease is a chronic neurodegenerative disorder which results in gradual degradation of the tissues of the brain. This hampers the normal functioning of the brain and impacts the daily liv...

Fibromyalgia (FM) is a medical condition characterised by chronic widespread pain and a heightened pain response to pressure.The APAC is a major untapped market with many leading vendors in the global...

Narcolepsy is a chronic neurological disorder and results from the inability of one s body to regulate sleep-wake cycles. ... These sleep periods can range from seconds or minutes and in most extreme...

Topamax, also known by its generic name topiramate, is a medication that belongs to the anticonvulsant class of drugs. It is primarily used for the treatment of epilepsy and to prevent migraine headac...

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dem...

Bipolar disorder, also known as manic depression, is a mental disorder that could lead to periods of depression and elevated mood.The global pharmaceutical market is 1475 billion USD in 2022, growing...

Donepezil is a medication used in the palliative treatment of Alzheimer's disease. Donepezil is used to improve cognition and behavior of people with Alzheimer's, but does not slow the progression of...

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumor...

Glatiramer is an immunomodulator medication currently used to treat multiple sclerosis.The Glatiramer market is primarily driven by the increasing demand for effective treatments for multiple sclerosi...

Glatiramer is an immunomodulator medication currently used to treat multiple sclerosis.The Glatiramer market is primarily driven by the increasing demand for effective treatments for multiple sclerosi...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

Migraine medication can provide headache relief for your pain. There are several types of migraine medications available, both over-the-counter (OTC) and prescription, that can help alleviate headache...

Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually gi...

Restless legs syndrome (RLS) is a neurological disease. RLS is also called as Willis-Ekbom disease. Patients suffering from RLS disease have an irresistible desire to move their feet. The continual mo...

Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually gi...

Bromperidol (marketed as Bromidol, Bromodol) is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophreniaThe global pharmaceuti...

Benzodiazepines are depressants that produce sedation and hypnosis, relieve anxiety and muscle spasms, and reduce seizures.The most common benzodiazepines are the prescription drugs Valium®, Xanax®, H...

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes...

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes...

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes...

Neuromyelitis optica (NMO) is an uncommon disease syndrome of the central nervous system (CNS) that affects the optic nerves and spinal cord. Individuals with NMO develop optic neuritis, which causes...

Donepezil base is the only new drug approved by FDA and MCA for symptomatic treatment of mild and moderate AD.Donepezil base is the only new drug approved by FDA and MCA for symptomatic treatment of m...

Etiracetam is a nootropic and anticonvulsant drug, primarily used for the treatment of epilepsy and other neurological disorders. It is a derivative of piracetam, which is one of the first nootropic c...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

Rizatriptan Benzoate Tablets are a medication used to treat acute migraine attacks in individuals with a history of migraines. Rizatriptan is a type of drug known as a serotonin (5-HT) receptor agonis...

Anticholinergic drugs for Parkinson’s disease (PD) are medications that block the action of acetylcholine in the brain to help balance the neurotransmitter activity disrupted by dopamine deficiency. T...

Anticholinergic drugs for Parkinson’s disease (PD) are medications that block the action of acetylcholine in the brain to help balance the neurotransmitter activity disrupted by dopamine deficiency. T...

Over-the-counter (OTC) migraine medications are non-prescription medications that can be purchased directly from a pharmacy or retail store without a doctor's prescription. These medicines are intende...

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strateg...

Trihexyphenidyl Drug for Parkinson’s disease (PD) are medications that block the action of acetylcholine in the brain to help balance the neurotransmitter activity disrupted by dopamine deficiency. Th...

According to our (Global Info Research) latest study, the global Guanfacine Hydrochloride API market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global Haloperidol Decanoate API market size was valued at US$ 624 million in 2025 and is forecast to a readjusted size of US$ 824 million by...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Aripiprazole market size was valued at US$ 1065 million in 2025 and is forecast to a readjusted size of US$ 1379 m...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Baclofen market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Brivaracetam market size was valued at US$ 920 million in 2025 and is forecast to a readjusted size of US$ 1239 mi...

According to our (Global Info Research) latest study, the global Pharmaceutical Grade Safinamide Mesylate market size was valued at US$ 579 million in 2025 and is forecast to a readjusted size of US$...

Psychedelic Drugs Market reached US$3.71 billion in 2025 and is expected to reach US$9.20 billion by 2033, growing with a CAGR of 12.10% during the forecast period 2026-2033. The Psychedelic Drugs Mar...

Traumatic Brain Injury Therapeutics Marketis is growing with a CAGR of 7.60% during the forecast period 2026-2035. The Traumatic Brain Injury Therapeutics Market emerges as a key focus in DataM Intell...

Drug-Resistant Epilepsy Market reached US$ 0.89 billion in 2025 and is expected to reach US$ 1.28 billion by 2033, growing with a CAGR of 4.40% during the forecast period 2026-2033. The Drug-Resistant...

Ischemic Stroke Treatment Market reached USD 9.4 billion in 2025 and is expected to reach USD 15.8 billion by 2033, growing with a CAGR of 7.60% during the forecast period 2026-2033. The Ischemic Stro...

Spinal Muscular Atrophy Market reached US$5.13 billion in 2025 and is expected to reach US$23.37 billion by 2033, growing with a CAGR of 16.50% during the forecast period 2026-2033. The Spinal Muscula...

Opioids Drug Marketis is growing with a CAGR of 3.30% during the forecast period 2026-2035. The Opioids Drug Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasone...

Sciatica Treatment Marketis is growing with a CAGR of 9.70% during the forecast period 2026-2035. The Sciatica Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, w...

Tardive Dyskinesia Treatment Marketis is growing with a CAGR of 12.60% during the forecast period 2026-2035. The Tardive Dyskinesia Treatment Market emerges as a key focus in DataM Intelligence latest...